Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have a clinically documented diagnosis of age-related cataract.~* Subjects must have clear intraocular media other than cataract.~* Subjects must be undergoing primary in-the-bag intraocular lens implantation for the correction of aphakia following continuous curvilinear anterior capsulotomy and phacoemulsification cataract extraction.~Exclusion Criteria:~* Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated.~* Subjects with diagnosis of degenerative visual disorder.~* Subjects who have any inflammation or edema (swelling) of the cornea.~* Subjects with immunodeficiency disorders.~* Subjects who have had previous intraocular surgery in the study eye.~* Subjects with incomplete/damaged zonule, or with conditions associated with increased risk of zonular rupture.~* Subjects with chronic use of systemic steroids or immunosuppressive medications.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Akreos MI Five-O (Type: EXPERIMENTAL): Accommodating intraocular lens

Based on this trial design, predict the completion outcome and termination type (if applicable).